Scn2a-related Developmental and Epileptic Encephalopathy

• CLINICAL_TRIALS research · 2025-08-21
  Clinical Trial Update: A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy [Phase 1, Phase 2]

  Praxis Precision Medicines is conducting a Phase 1/2 clinical trial of PRAX-222 in pediatric participants with SCN2A-related developmental a…